Introduction
Nuclear factor kB (NF-kB) plays a pivotal role in regulation of T lymphocyte activation and many other aspects of immune responses (Gerondakis et al., 1998; Ghosh et al., 1998) . In resting T cells, the activity of NF-kB is tightly controlled through its cytoplasmic sequestration by speci®c inhibitors, including IkBa and related proteins (Baldwin, 1996) . NF-kB nuclear expression can be stimulated by ligands or agonistic monoclonal antibodies (mAb) for the T-cell receptor (TCR) and the costimulatory molecule CD28 (Bryan et al., 1994; Ghosh et al., 1993) . Activation of NF-kB by these T-cell costimulatory agents or in¯ammatory cytokines is mediated through phosphorylation of IkBa (Brockman et al., 1995; Brown et al., 1995; Harhaj et al., 1996; Lai and Tan, 1994) , which in turn targets this inhibitor for degradation through the ubiquitin-proteasome pathway (Chen et al., 1995) . Since the degraded IkBa can be rapidly replenished through NF-kBinduced IkBa gene expression, NF-kB nuclear expression normally occurs transiently, thus ensuring a rapid but transient induction of the target genes (Chiao et al., 1994; de Martin et al., 1993; Le Bail et al., 1993; Scott et al., 1993; Sun et al., 1993) . However, when T cells are infected with the human T-cell leukemia virus type I (HTLV-I), NF-kB becomes constitutively nuclear, resulting in aberrant expression of various growth-regulatory cellular genes (Arima et al., 1991; Ballard et al., 1988; Leung and Nabel, 1988; Ruben et al., 1988) . This pathogenic action of HTLV is mediated through its transactivator protein Tax, which stimulates chronic phosphorylation and degradation of IkBa (Brockman et al., 1995; Lacoste et al., 1995; Sun et al., 1994 ; for a recent review see Sun and Ballard, 1999) .
Recent studies have demonstrated that induction of IkBa phosphorylation by cytokines, mitogens, and Tax, is mediated by a multicomponent IkB kinase (IKK) (Geleziunas et al., 1998; Harhaj and Sun, 1998; Uhlik et al., 1998; Yamaoka et al., 1998; Yin et al., 1998; Zandi and Karin, 1999) . The IKK complex is composed of two catalytic subunits, IKKa and IKKb (DiDonato et al., 1997; Mercurio et al., 1997; Regnier et al., 1997; Woronicz et al., 1997; Zandi et al., 1997) and a noncatalytic subunit, termed IKKg (also called NEMO, IKKAP1, or FIP-3) Mercurio et al., 1999; Rothwarf et al., 1998; Yamaoka et al., 1998) . How IKK is activated by the diverse signals remains unclear. When overexpressed in mammalian cells, a number of upstream kinases activate IKK; these include two MAP kinase kinase kinases (MAP3K), MEK kinase 1 (MEKK1) and NF-kB inducing kinase (NIK) (Lee et al., 1998; Ling et al., 1998; Nakano et al., 1998; Nemoto et al., 1998) . Consistently, dominant-negative forms of NIK and MEKK1 interfere with IKK activation stimulated by both cytokines and Tax (Geleziunas et al., 1998; Uhlik et al., 1998; Yin et al., 1998; Zandi and Karin, 1999) . However, evidence supporting the physiological role of these MAP3Ks in IKK regulation is lacking. In fact, emerging evidence indicates that the eect of overexpressed MAP3Ks on IKK activity may not be speci®c or physiological (Rothwarf and Karin, 1999) . Thus, a better understanding of the IKK signaling pathways initiated by dierent stimuli, such as cytokines, Tax, and T-cell activation agents, relies on genetic approaches.
In this study, we performed somatic cell mutagenesis (McKendry et al., 1991) to isolate mutant T cell lines defective in NF-kB signaling. One of the mutant cell lines has a de®ciency in IKKg expression. We demonstrate that the IKKg de®ciency results in a blockade in NF-kB activation triggered by both the Tcell costimulation signals and HTLV-I Tax; this signaling defect can be rescued by expression of exogenous IKKg. These ®ndings provide genetic evidence for the requirement of IKKg in NF-kB signaling triggered by both T-cell costimulatory signals and HTLV-I Tax protein.
Results

Isolation of a mutant Jurkat T-cell line defective in kB activation by T-cell mitogens
In T cells, NF-kB activation can be potently stimulated by monoclonal antibodies recognizing the CD3 chains of TCR (anti-CD3) and the costimulatory molecule CD28 (anti-CD28) (Bryan et al., 1994; Ghosh et al., 1993) . These costimulatory signals can also be triggered by the mitogen phorbol 12-myristic 13-acetate (PMA) together with anti-CD28 (Harhaj et al., 1996; Lai and Tan, 1994) . To undertake a molecular dissection of the NF-kB signaling pathway, we performed somatic mutagenesis to isolate mutant cell lines defective in NF-kB activation by PMA/anti-CD28. For these studies, we used a parental Jurkat T-cell line stably transfected with a CD14 reporter gene under the control of NF-kB binding site, kB (SVT35, Ting et al., 1996) . As expected, high levels of surface CD14 expression could be induced in these parental cells following stimulation with PMA/anti-CD28 (Figure 1a , lower left panel). To minimize the frequency of isolating mutant cells carrying cis-mutations (mutations in the CD14 reporter gene), an endogenous NF-kB target gene, CD25, was used as a second reporter. For mutagenesis, the SVT35 cells were treated with a chemical mutagen, ICR191, followed by mitogen stimulation. Mutant cells incapable of inducible kB-CD14 expression were isolated by¯uorescence activated cell sorting (FACS) and cloned by limiting dilution. The cell clones were subjected to FACS analyses to identify those incapable of expressing the kB-driven CD14 reporter and the endogenous CD25 gene in response to the inducers. A number of such mutant cell clones were isolated, one of which, termed JM4.5.2, was characterized in detail. As shown in Figure 1a , neither the CD14 reporter gene nor the endogenous CD25 gene was induced when the mutant cells were stimulated by the T-cell stimuli (Figure 1 , lower right panel). The defect in NF-kB activation of the JM4.5.2 cell line was further con®rmed by luciferase reporter gene assays. As shown in Figure  1b , while the kB-driven luciferase gene was strongly induced in the parental cells, induction of this kBspeci®c reporter was largely blocked in the mutant cells.
Signal-induced IkB phosphorylation and degradation is blocked in the mutant T cells
To identify the NF-kB signaling steps aected by the mutation in JM4.5.2 cells, inducible phosphorylation and degradation of IkBa was examined using both the showed that the signaling defect in IkBa phosphorylation and degradation was associated with a blockade of NF-kB activation in mitogen-induced JM4.5.2 cells (lanes 8 ± 12). Thus, the JM4.5.2 cells appeared to have a defect in activation or function of the IKK.
We have previously shown that phosphorylation of IkBa can also be induced by a phosphatase inhibitor, calyculin A . Unlike that seen with mitogens and cytokines, calyculin A-induced IkBa phosphorylation is insensitive to inhibitors that block upstream steps in NF-kB signaling , suggesting that the action of this phosphatase inhibitor may bypass upstream signaling events. To better understand the signaling defect of the JM4.5.2 cells, we examined the calyculin A-induced IkBa phosphorylation in the parental and mutant Jurkat T cells. As expected, calyculin A eciently induced IkBa phosphorylation in the parental JSVT.35 cells (Figure 2a , upper panel, lanes 6 and 7), although the degradation of IkBa exhibited a delayed kinetics (lanes 6 and 7 and . Interestingly, the JM4.5.2 mutant cells still responded to calyculin A for phosphorylation of IkBa (lanes 13 and 14). Consistently, calyculin A also induced a certain level of NF-kB DNA binding activity in the JM4.5.2 cells (Figure 2a , lower panel, lanes 13 and 14). These results indicate that the JM4.5.2 cells may contain functional IKK catalytic subunits, but they can not be activated by upstream signals due to speci®c signaling defects. Calyculin A may bypass the upstream signaling defect by inducing IkBa phosphorylation through inhibiting IKK-opposing phosphatases (DiDonato et al., 1997) .
While IkBa serves as the major inhibitor of the inducible form of NF-kB, IkBb appears to play a role in mediating more persistent NF-kB activation McKinsey et al., 1996; Thompson et al., A Figure 2 The JM4.5.2 cells are defective in signal-induced phosphorylation and degradation of IkBa and IkBb. (a) The parental and mutant Jurkat T cells were either not treated (NT) or stimulated with the indicated T-cell mitogens or the phosphatase inhibitor calyculin A (Cal A, 50 ng/ml). Whole-cell extracts were subjected to immunoblotting (upper panel) using anti-IkBa antibody. The more slowly migrating band was previously demonstrated to be the phosphorylated IkBa (Brockman et al., 1995; Brown et al., 1995; Sun et al., , 1996 . A parallel EMSA was performed using nuclear extracts and a 32 P-radiolabeled kB oligonucleotide probe (lower panel). The composition of the two NF-kB complexes have been previously reported (Harhaj et al., 1996) . (b) The parental and mutant Jurkat T cells were preincubated for 30 min with a proteasome inhibitor, MG132 (25 mM), and then stimulated with PMA/anti-CD28. Phosphorylation of IkBa was analysed by immunoblotting. The more slowly migrating band represents the phosphorylated IkBa (IkBa-P). (c) The cell extracts from A were subjected to immunoblotting using anti-IkBb antibody 1995). Compared to that of IkBa, the degradation of IkBb appears to require a higher threshold of stimulation signals. In T cells, IkBb degradation requires not only the mitogen PMA but also the CD28 costimulatory signal (Harhaj et al., 1996) . It has remained unclear whether the inducible degradation of this NF-kB inhibitor depends on IKK activation. We addressed this question by analysing the fate of IkBb protein in the parental and mutant Jurkat T cells along with signal stimulation. As expected (Harhaj et al., 1996) , costimulation of the parental Jurkat cells with PMA and anti-CD28 induced marked loss of IkBb protein (Figure 2c , upper panel, lanes 4 and 5), although PMA was an inecient inducer in the absence of the CD28 signal (lanes 2 and 3) . Further, IkBb degradation was also readily detected in calyculin A-treated cells (lanes 6 and 7). More importantly, in the JM4.5.2 cells, the PMA/anti-CD28-induced IkBb degradation was completely blocked (Figure 2c , lower panel, lanes 4 and 5), suggesting the requirement of the IKK signaling machinery in degradation of this NF-kB inhibitor. Furthermore, as seen with IkBa, IkBb was still degraded by calyculin A in the JM4.5.2 mutant cells (Figure 2c , lower panel, lanes 6 and 7). However, the level of IkBb degradation appeared to be slightly lower in the calyculin A-treated JM4.5.2 cells than that in the calyculin A-treated JSVT35 cells. This subtle dierence in IkBb degradation may contribute to the dierence in calyculin A-induced NF-kB DNA binding activity (Figure 2a , lower panel, compare lanes 6 and 7 with lanes 13 and 14).
Activation of IKK, but not JNK and MAPKs, is blocked in JM4.5.2 cells
We then examined the catalytic activity of IKK in stimulated Jurkat and JM4.5.2 T cells by immunecomplex kinase assays. As we recently reported , IKK was potently activated in the parental Jurkat T cells stimulated with PMA and anti-CD28 (Figure 3a , upper panel, lane 2). Similarly, another mitogen-induced kinase, the c-Jun N-terminal kinase (JNK), was also strongly induced by PMA or PMA/anti-CD28 (lanes 4 and 5). More importantly, signal-mediated activation of the catalytic activity of IKK was largely blocked in the JM4.5.2 cells ( Figure  3a , lower panel, lane 2), while activation of JNK remained competent (lanes 4 and 5). Using phosphorylation-speci®c antibodies, we also found that the inducible phosphorylation of ERKs and p38 was not aected in the mutant cells (Figure 3b) , suggesting that these MAPK pathways also remained intact in the JM4.5.2 cells.
The JM4.5.2 cells are defective in NF-kB activation by both mitogens and the HTLV-1 Tax protein
To examine whether the NF-kB signaling defect in the JM4.5.2 cells also aected Tax-mediated NF-kB activation, luciferase reporter gene assays were performed in transiently transfected cells. As expected, the T-cell costimulatory agents PMA/anti-CD28 potently stimulated the transcription of a kB-speci®c reporter gene in the parental Jurkat T cells (Figure 4a , column 2) but not in the JM4.5.2 mutant cells (column 4). More importantly, the JM4.5.2 cells also had a blockade in Tax-mediated induction of the kB enhancer (Figure 4b ). While the kB-TATA-Luc reporter was potently induced by Tax in the parental cells (column 2), this reporter was only slightly induced in the mutant cells (column 4). Thus, the genetic mutation harbored by the JM4.5.2 cells aects NF-kB activation by both the mitogens and Tax.
Prior studies suggest that Tax transactivates target genes by activating dierent cellular transcription factors, most importantly the NF-kB and the CREB/ ATF pathways . While the CREB/ATF pathway is required for Tax activation of the HTLV-I long terminal repeat (LTR), the NF-kB pathway mediates Tax activation of various cellular genes regulated by the kB enhancer. To examine Whole-cell extracts were isolated from the indicated cells and subjected to immunoblotting using antibodies speci®cally reacting with phosphorylated p38 (p38-P) or ERK1 and ERK2 (ERK1-P/ERK2-P). The expression level of p38 and ERKs was detected by immunoblots using regular antibodies for these proteins (p38 and ERKs) whether the molecular mutation in the JM4.5.2 cells selectively aected the NF-kB pathway, a control reporter gene assay was performed to examine Taxmediated transactivation of a luciferase reporter driven by the HTLV-I LTR (Figure 4c ). In sharp contrast to that seen with the kB enhancer, HTLV-I LTR-Luc was still potently induced by Tax in the mutant cells (Figure 4c, column 4) . Thus, the signaling defect of the JM4.5.2 cells does not signi®cantly aect Tax-mediated activation of CREB/ATF factors.
Lack of IKKg expression contributes to the signaling defect of the JM4.5.2 cells
To characterize the signaling defect of the JM4.5.2 cells, we performed immunoblotting assays to examine expression of various proteins known to be involved in the activation and function of NF-kB. The parental and mutant cells expressed similar amounts of various NF-kB/IkB proteins, including IkBa, IkBb, c-Rel, and RelA (Figure 5a) . A number of protein kinases were also expressed at normal levels in the JM4.5.2 cells; these include IKKa, IKKb, MEKK1, and the mixed lineage kinase 3 (MLK3) (Figure 5a ). Interestingly, immunoblotting analyses of the IKKg protein revealed that this subunit of IKK was completely absent from the JM4.5.2 cells but was readily detected from the parental Jurkat T cells (Figure 5a, IKKg) . As previously reported (Rothwarf et al., 1998) , two forms of IKKg could be detected from the parental Jurkat cells (arrowheads). Both forms were missing from the mutant cells.
To determine whether the lack of IKKg contributed to the signaling defect of the mutant cells, reporter gene assays were performed to examine the eect of exogenously transfected IKK components on activation of the kB-TATA-Luc reporter gene in JM4.5.2 cells. In the absence of a stimulus, none of the IKK components induced the kB reporter. Expression of IKKa or IKKb also failed to generate any signi®cant eect on the induction of the kB reporter by PMA/ anti-CD28 (Figure 5b , columns 8 and 9). In sharp contrast, when the mutant cells were transfected with the IKKg expression vector, the signal-stimulated kB activation was largely restored (column 10). Studies performed with Tax-transfected cells revealed a similar result, where IKKg eciently restored Tax-mediated NF-kB signaling (Figure 5c ). These results suggest that the IKKg de®ciency in JM4.5.2 cells contributes to the defect in NF-kB induction by both Tax and mitogens.
We also examined whether IKKg expression could rescue the inducible expression of the stably transfected CD14 reporter gene and the endogenous CD25 gene, since these genes were used for the isolation of the mutant cell line. For these studies, the IKKg cDNA expression vector was introduced to JM4.5.2 cells using a retroviral vector. The expression of CD14 and CD25 on the surface of SVT35 (parental cell), JM4.5.2, and JM4.5.2-IKKg cells were analysed by FACS. As shown in Figure 5d , the inducible expression of both indicator genes was largely restored in the JM4.5.2 cells following expression of the exogenous IKKg ( Figure  5d, right panel) . J.SVT35, JM4.5.2, or JM4.5.2 infected with a recombinant retrovirus encoding IKKg were either not treated (NT) or stimulated for 8 h with PMA together with anti-CD28. The cells were incubated with anti-CD14PE and anti-CD25FITC and then subjected to two-color FACS analyses as described in Figure 1a deregulated nuclear expression of NF-kB and abnormal T-cell growth (Ressler et al., 1996) . We and others have recently shown that IKK serves as a target for both T-cell costimulatory signals and the HTLV-I Tax protein (Geleziunas et al., 1998; Uhlik et al., 1998; Yin et al., 1998) . However, the signaling steps involved in IKK activation by dierent cellular and viral stimuli remain unclear. Studies performed in rat ®broblast (Rat-1) and murine pre-B (70Z.3) cell lines demonstrate that the noncatalytic IKK component IKKg plays an essential role for NFkB activation by cytokines and mitogens (Yamaoka et al., 1998) . However, the role of IKKg in Tax-speci®c NF-kB signaling remains obscure. While IKKg is essential for the Tax-stimulated NF-kB activation in Rat-1 cells, this IKK component is completely dispensable for the Tax/NF-kB signaling in 70Z.3 cells (Courtois et al., 1997; Yamaoka et al., 1998) . This discrepancy is likely caused by the dierent cell types used in the studies. Since HTLV-I speci®cally transforms human T cells, it is essential to study the mechanism of Tax-initiated NF-kB signaling in the T lymphocyte environment. Additionally, a T-cell system is also required for studying the mechanism by which T-cell costimulatory signals activate IKK. In the current study, we studied the NF-kB signaling pathway in Jurkat T cells using a genetic approach. By somatic mutagenesis, we have isolated a mutant cell line (JM4.5.2) lacking expression of IKKg. This genetic de®ciency is associated with a blockade in NF-kB signaling induced by both the T-cell costimulatory agents and Tax. We show that this signaling defect can be rescued by expression of exogenous IKKg. Thus, IKKg serves as an essential component in NF-kB signaling triggered by both T-cell costimulatory signals and Tax.
The mechanism by which IKKg responds to diverse upstream signals remains to be further investigated. One possibility is that IKKg interacts with and recruits upstream activators to the IKK catalytic subunits, triggering phosphorylation-dependent activation of IKK (Zandi and Karin, 1999) . Several upstream kinases, such as NIK and MEKK1, have been proposed to serve as IKK kinases (Lee et al., 1998; Ling et al., 1998; Nakano et al., 1998; Nemoto et al., 1998) . When overexpressed in 293 kidney carcinoma cells, NIK physically interacts with IKKg . However, at least under transient transfection conditions, IKKg does not seem to be essential for NIK-induced NF-kB activation (data not shown). Thus, the physiological role of the NIK/IKKg interaction in IKK activation remains elusive. MEKK1 has been shown to directly activate IKKb in overexpressed cells (Lee et al., 1998; Nakano et al., 1998; Nemoto et al., 1998) and cells transiently transfected with Tax (Yin et al., 1998) . Of note, MEKK1, as well as its downstream JNK signalin pathway, is functional in the IKKg-de®cient JM4.5.2 cell line but can not mediate IKK activation upon T-cell costimulation (this study). It remains to be investigated whether the failure of MEKK1 to activate IKK under these conditions is due to the lack of IKKg. These studies will determine whether MEKK1 is required for IKK activation in T cells.
More recently, IKKg has been shown to interact with the viral protein Tax in both transiently transfected and HTLV-I-infected human T cells (Harhaj and Sun, 1999; Jin et al., 1999) . Interestingly, IKKg appears to serve as an adaptor recruiting Tax to the IKK catalytic subunits, IKKa and IKKb (Chu et al., 1999; Harhaj and Sun, 1999; Jin et al., 1999) . A Tax mutant, M22, defective in NF-kB activation fails to interact with IKKg (Harhaj and Sun, 1999) . These ®ndings suggest that the Tax/IKKg interaction may serve as a molecular trigger for IKK activation. This notion is further supported by the results obtained from the current genetic studies.
Materials and methods
Cell lines, reagents and antibodies
Human 293 embryonic kidney cells were cultured in Dulbecco's medium supplemented with 10% fetal bovine serum, 2 mM L-glutamine, and antibiotics. Jurkat SVT35 (J.SVT35) is a subline of the human Jurkat leukemic T-cells stably transfected with a CD14 reporter gene driven by eight copies of an NF-kB binding site, kB (kindly provided by Dr Brian Seed, Ting et al., 1996) . These cells were maintained in RPMI 1640 medium supplemented with 10% fetal bovine serum, 2 mM L-glutamine, and antibiotics. For selection of the reporter gene, the cells were periodically cultured for 2-week intervals in the RPMI medium containing GPT selection drugs (5 mg/ml mycophenolic acid, 250 mg/ml xanthine, 100 mg hypoxanthine). PMA and ionomycin were purchased from Sigma and used at a concentration of 10 ng/ ml and 1 mM, respectively. The monoclonal antibody for human CD28 (anti-CD28, clone 9.3) was provided by The Fred Hutchinson Cancer Research Center and used at 1 : 10 000 dilution (or 0.3 mg/ml). The anti-IKKg monoclonal antibody was from IMGENEX (San Diego, CA, USA). The peptide-speci®c polyclonal antisera for RelA, c-Rel, and IkBa were described previously (Harhaj et al,. 1996) . The phycoerythrin (PE)-conjugated anti-CD14 and FITC-conjugated anti-CD25 monoclonal antibodies were from Pharmingen. The phospho-speci®c antibodies for p38 and ERK1/ ERK2 were from New England Biolabs, Inc. All the other antibodies were obtained from Santa Cruz Biotechnology, Inc.
Plasmid constructs
The luciferase reporters driven by the kB enhancer (kB-TATA-Luc) or the long terminal repeat of HTLV-I (HTLV-I LTR-Luc) and various cDNA expression vectors were described previously (Harhaj and Sun, 1999; Uhlik et al., 1998) . Human cDNA for IKKg was cloned from Jurkat T cells by RT ± PCR and inserted into a pcDNA expression vector carrying the hemaglutinin epitope tag (pcDNA-HA, Harhaj and Sun, 1999) . The retroviral vector pCLXSN and the packaging plasmid pCL-Ampho were provided by Dr Inder Verma (Naviaux et al., 1996) . To generate an IKKg retroviral expression vector (pCLXSN ± IKKg), the IKKg cDNA was subcloned into the pCLXSN vector.
Isolation of mutant T-cell lines by somatic mutagenesis J.SVT35 were incubated for 5 h in RPMI media supplemented with 4 mg/ml of an alkylating agent ICR191 (Sigma), a treatment resulting in approximately 95% of cell death. The treated cells were washed twice with RPMI medium and then resuspended in the same medium to allow the remaining cells to recover. When the cells reached a density of 5610 5 cells/ml, dead cells were removed by using Ficoll/Paque columns (Pharmacia Biotechnology), and the live cells were resuspended in RPMI medium followed by a second round of ICR191 treatment. A total of three rounds of mutagenesis were performed to ensure high frequency of mutations (McKendry et al., 1991) . After the ®nal round of mutagenesis, the cells were stimulated with PMA (10 ng/ml) plus anti-CD28 (clone 9.3, 1 : 10 000 dilution) for 12 h and then stained with a PEconjugated anti-CD14. Mutagenized cells defective in kB activation were enriched by three successive rounds of¯ow cytometric sorting for CD14-negative cells, and the enriched cells were subjected to limiting dilution in microtiter plates. Puri®ed cell clones were stimulated for 8 ± 12 h with PMA/anti-CD28 followed double staining with anti-CD14 and anti-CD25 and two-color FACS analyses for surface expression of the CD14 reporter and an endogenous NF-kB target gene, CD25. Cell clones defective in the inducible expression of both CD14 and CD25 were isolated for further analyses. We found that the use of an endogenous NF-kB-target gene as a second reporter signi®cantly reduced the number of false positive clones. To select those cells that have a blockade in signal transduction rather than a defect in the function of nuclear factors, the isolated mutant cell clones were subjected to immunoblotting analyses for signal-mediated IkBa phosphorylation. Only those clones defective in the inducible IkBa phosphorylation were selected for further analyses.
Transient transfection, and luciferase assays
Parental or mutant Jurkat cells (1.25610 6 were transfected using DEAE-dextran (Holbrook et al., 1987) with 40 ng of kB-TATA-Luc reporter together with the indicated eector cDNA expression vectors. Tax was transfected at 0.125 mg, and the amounts for the other expression vectors were as indicated in the ®gures or ®gure legends. At 40 h post transfection, the recipient cells were treated for 8 h with PMA plus anti-CD28 and then subjected to extract preparation using a reporter lysis buer (Luciferase reagent, Promega) at about 100 ml per 10 6 cells. Luciferase activity was detected by mixing 5 ml extract with 25 ml luciferase substrate (Promega) and measured with a luminometer.
Retroviral transduction
293 cells were seeded at a density of 2610 5 cells/well in a 6-well plate. The next day, cells were transfected using the Fugene reagent (Boehringer Mannheim) with 1 mg of pCLXSN-IKKg and 1 mg of pCL-Ampho. Forty-eight hours post-transfection, the viral supernatant was collected, ®ltered through a 0.45 m polysulfone ®lter and used to infect JM4.5.2 cells. Brie¯y, 1610 6 JM4.5.2 cells were resuspended in 2 ml of high titer viral supernatant in 8 mg/ml polybrene, placed in a 6-well plate and spun in a microtiter rotor at 1800 r.p.m. for 45 min at room temperature. Forty-eight hours postinfection, the infected cells were placed in regular growth media supplemented with 1 mg/ml G418 for selection of the stably infected cells.
Cell extract preparation, immunoblotting and electrophoretic mobility shift assays (EMSA)
Parental or mutant Jurkat cells were either not treated or treated as indicated in the ®gure legends and then collected by centrifugation at 800 g for 5 min. Whole-cell extracts were prepared and subjected to immunoblotting analyses as previously described (Ganchi et al., 1992; Sun et al., 1993) . Nuclear extracts were isolated using a minipreparation protocol (Schreiber et al., 1989) and immediately subjected to EMSA. Brie¯y, nuclear extracts (*6 mg) were incubated at room temperature for 10 min with a 32 P-radiolabeled highanity palindromic kB probe, kB-pd (coding strand sequence was 5'-CAACGGCAGGGGAATTCCCCTCTCCTT-3') followed by resolving the DNA-protein complexes on native 5% polyacrylamide gels.
Immunecomplex kinase assays J.SVT35 or mutant cells were treated as indicated in the ®gure legends and then lysed in a lysis buer, containing 20 mM HEPES (pH 7.6), 250 mM NaCl, 0.5% NP-40, 20 mM b-glycerophosphate, 1 mM EDTA, 20 mM p-nitrophenylphosphate (PNPP), 0.1 mM Na 3 VO 4 , 1 mM dithiothreitol (DTT), 1 mM phenylmethylsulfonyl¯uoride (PMSF), and a previously described protease inhibitor cocktail (Ballard et al., 1990) . IKK and JNK were isolated by immunoprecipitation (IP) using anti-IKKa and anti-JNK1 antibodies, respectively. The catalytic activity of IKK and JNK was detected by immunecomplex kinase assays as described (Uhlik et al., 1998) using the GST-IkBa (1-54) and GST-c-Jun (1-79) substrates, respectively.
